Network Pharmacology-Based Analysis of Xiao-Xu-Ming Decoction on the Treatment of Alzheimer ’s Disease
In conclusion, XXMD was found to have the potential to treat AD by targeting multiple AD-related targets and canonical pathways. Fangchinoline and dauricine might be the potential lead compounds in XXMD for the treatment of AD.
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research
More News: Alzheimer's | Biology | Brain | China Health | Chloride | Databases & Libraries | Drugs & Pharmacology | Klor-Con | Molecular Biology | Neurology | Potassium | Potassium Chloride | Sodium | Stroke | Study | Taiwan Health | Toxicology